Admira 40mg/0.8ml Injection
Marketer
Tricept Life Sciences Private Limited
Salt Composition
Adalimumab (40mg/0.8ml)
Overview Admira 40mg/0.8ml Injection
Arthritis-related inflammation and related conditions like Crohn's disease and ulcerative colitis respond to treatment with the 40mg/0.8ml Admira Injection. This medication alleviates pain, swelling, and redness, enhancing mobility. Administered by a medical professional, Admira requires consistent daily dosing for optimal results. Complete the prescribed course, even with symptom improvement. Potential side effects include headaches, sinus issues, skin rashes, upper respiratory infections, and injection site reactions (pain, redness, swelling). Consult your physician if side effects persist or worsen; management strategies are available. Prior to use, disclose any heart, kidney, or liver conditions, and all other medications to your doctor. Pregnant or breastfeeding individuals should seek medical counsel before commencing treatment.
Uses of Admira 40mg/0.8ml Injection
Spondylitis ankylosans | Rheumatoid arthritis | Psoriatic arthritis | Ulcerative colitis | Crohn's disease
Major Benefits of Admira 40mg/0.8ml Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Admira 40mg/0.8ml Injection:
- Headache
- Sinus inflammation
- Rash
- Upper respiratory tract infection
- Injection site reaction
How to use Admira 40mg/0.8ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Admira 40mg/0.8ml Injection works:
Admira 40mg/0.8ml Injection inhibits specific inflammatory mediators, thereby reducing the swelling, redness, and inflammation characteristic of some arthritic conditions.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Admira 40mg/0.8ml Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Admira, 40mg/0.8ml, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Admira 40mg/0.8ml Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
The Admira 40mg/0.8ml Injection can produce adverse reactions, including dizziness and blurred vision, potentially impairing driving skills.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Admira 40mg/0.8ml Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data on Admira 40mg/0.8ml Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Admira 40mg/0.8ml Injection :
Omit a dose of Admira 40mg/0.8ml Injection? Seek your physician's advice.
Facts to Know About Admira 40mg/0.8ml Injection
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs) |
3,018 People bought this recently